- Investing Ideas
- /
- Global Strong Balance Sheet Stocks
Global Strong Balance Sheet Stocks
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
3,909 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIXAnixa Biosciences | US$3.13 | -18.9% | 9.4% | US$93.7m | US$11.00 | PS182.9x | E-8.3% | n/a | Pharmaceuticals & Biotech | ||
| REFRResearch Frontiers | US$1.95 | -5.8% | -31.1% | US$61.7m | n/a | PS52.3x | n/a | n/a | Tech | ||
| BYFCBroadway Financial | US$2.60 | 5.3% | 45.3% | US$186.6m | n/a | PB1.3x | n/a | 0% | Banks | ||
| NTZNatuzzi | US$15.40 | -6.7% | 30.6% | US$168.9m | n/a | PB1.9x | n/a | n/a | Consumer Durables | ||
| MACKMerrimack Pharmaceuticals | US$4.10 | -2.1% | -44.1% | US$55.0m | n/a | PB3.8x | n/a | n/a | Pharmaceuticals & Biotech | ||
| VBLTVascular Biogenics | US$2.06 | -11.2% | 44.1% | US$142.8m | US$5.50 | PS183.8x | E46.5% | n/a | Pharmaceuticals & Biotech | ||
| PPSIPioneer Power Solutions | US$7.33 | -3.9% | 56.0% | US$64.0m | n/a | PS3.2x | n/a | n/a | Capital Goods | ||
| MCHXMarchex | US$2.52 | -3.8% | 5.0% | US$102.1m | US$4.38 | PS1.9x | E-43.3% | 0% | Media | ||
| CLDXCelldex Therapeutics | US$36.42 | -5.9% | 94.8% | US$1.7b | US$65.17 | PS209.8x | E-19.1% | n/a | Pharmaceuticals & Biotech | ||
| SRRASierra Oncology | US$23.40 | -0.4% | 59.6% | US$352.3m | US$37.00 | PS1762x | E46.8% | n/a | Pharmaceuticals & Biotech | ||
| LTBRLightbridge | US$7.94 | -18.7% | 97.5% | US$60.6m | n/a | PB3.9x | n/a | n/a | Energy | ||
| CHNRChina Natural Resources | US$0.82 | -14.0% | -47.4% | US$33.6m | n/a | PB2.1x | n/a | n/a | Materials | ||
| DRNADicerna Pharmaceuticals | US$38.18 | 0.3% | 56.2% | US$3.0b | US$34.96 | PS15.5x | E-8.1% | n/a | Pharmaceuticals & Biotech | ||
| CTMXCytomX Therapeutics | US$5.73 | -12.1% | -21.2% | US$373.9m | US$12.86 | PS5.6x | E-19.1% | n/a | Pharmaceuticals & Biotech | ||
| NEXTNextDecade | US$3.07 | -7.0% | 19.0% | US$380.2m | US$4.42 | PB12x | E-57.5% | n/a | Energy | ||
| MDGLMadrigal Pharmaceuticals | US$77.23 | -5.6% | -36.1% | US$1.3b | US$170.08 | PB5.6x | E56.1% | n/a | Pharmaceuticals & Biotech | ||
| ACRSAclaris Therapeutics | US$12.64 | 3.0% | 208.3% | US$773.9m | US$34.67 | PS113.2x | E-6.1% | n/a | Pharmaceuticals & Biotech | ||
| USAUU.S. Gold | US$9.98 | -3.6% | -10.0% | US$70.8m | US$20.50 | PB2.6x | n/a | n/a | Materials | ||
| NAOVNanoVibronix | US$1.14 | -0.9% | 14.0% | US$32.0m | n/a | PS31.7x | n/a | n/a | Healthcare | ||
| GIGAGiga-tronics | US$3.63 | -4.2% | 11.7% | US$9.9m | n/a | PB3.9x | n/a | n/a | Capital Goods | ||
| SLNC.FSilence Therapeutics | US$7.47 | 4.5% | 28.8% | US$671.0m | n/a | PS44.6x | E-31.9% | n/a | Pharmaceuticals & Biotech | ||
| GTBPGT Biopharma | US$3.29 | -20.9% | -7.8% | US$100.4m | US$25.33 | PB3.1x | E-19.9% | n/a | Pharmaceuticals & Biotech | ||
| ENZNEnzon Pharmaceuticals | US$0.39 | 4.4% | 84.0% | US$29.3m | n/a | PS41.5x | n/a | n/a | Pharmaceuticals & Biotech | ||
| GDRZ.FGold Reserve | US$1.33 | 0.8% | -10.8% | US$132.4m | n/a | PB2.1x | n/a | n/a | Materials |